-
BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable Syringe in One Integrated System
b3cnewswire
October 22, 2019
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD Intevia™ 1mL two-step disposable autoinjector ...
-
BD to market its Venovo™ Venous Stent
biospectrumasia
March 19, 2019
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive d
-
PDL BioPharma Appoints BD VP
contractpharma
May 22, 2018
Jill M. Jene, Ph.D. has been appointed vice president, business development, PDL BioPharma, Inc
-
AGC Biologics sign up new Sr. Vice Presidents of BD
biospectrumasia
March 15, 2018
Schleyer as Senior Vice President of Business Development, North America, and Christoph Winterhalter as Senior Vice President of Business Development, Europe
-
BD Announces Results of Offer to Repurchase its 3.000% Notes Due 2026
biospace
March 05, 2018
BD announced today the results of its previously announced offer to repurchase (the "Offer") any and all of its outstanding 3.000% Notes due May 15, 2026 (the "Notes")